Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Remain positive, keep an eye on the finish line
2016-10-28

Description: Remain positive Tags: Remain positive

Photo: iStock

No one is immune to anxiety, and the current challenging academic times are no exception. With the Academic Reboot Pack 2.0, the University of the Free State (UFS) addresses these adversities.

Dealing with anxiety differently
People react to anxiety differently. For some it’s like a dark tunnel with no light at the end, while it keeps others on their toes. Regardless of how you deal with it, it is still an unpleasant emotion.

“For me, it (anxiety) makes me more determined to do well, so that I can start the next part of my life as soon as possible,” said Greg Butters, a postgraduate BCom Accounting student at the UFS.

Ways to manage and overcome
There are different ways to manage anxiety. Here are some methods that can assist you in dealing with it:

Keep the following in mind when you are feeling anxious:
•    Realise that anxiety is an amplified response to stress.
•    Face your anxiety head-on.
•    Do not add to your anxiety by thinking about what "might" happen. If you find yourself asking "What if?" tell yourself "So what!"

Where to get the right help

It is also important to know that there is help. When you feel that anxiety is affecting you negatively, pick up a phone and call one of the following departments:

•    Medical Practice: +27 51 401 2603
•    Qwaqwa Campus Clinic: +27 58 718 5210
•    Sports and Exercise Medicine Clinic: +27 51 401 2530
•    First Aid: +27 51 401 3325
•    Emergencies (After hours) - ER 24: 0800 051 051 or 084 124

If you feel that you are managing you anxiety, but would like to develop your skills further, please make an appointment with Student Counselling and Development at: HerbstP@ufs.ac.za or phone +27 51 401 2853.

You can also contact the South African Depression and Anxiety Group (SADAG) 24-hour helpline. SADAG has various helplines that can help you deal with anxiety and depression.

Get your copy of the Academic Reboot Pack 2.0 on Blackboard under announcements or click here to download it.

Also see the first Academic Reboot Pack.

If students have any question or queries regarding the Academic Reboot Pack, they can send an email to: advising@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept